After finishing at $0.74 in the prior trading day, PaxMedica Inc (NASDAQ: PXMD) closed at $0.66, down -10.81%. On the day, 3469167 shares were traded. PXMD stock price reached its highest trading level at $0.7682 during the session, while it also had its lowest trading level at $0.5500.
Ratios:
Our goal is to gain a better understanding of PXMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.16 and its Current Ratio is at 3.16. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 29 ’24 when Rome Zachary sold 811 shares for $0.48 per share. The transaction valued at 389 led to the insider holds 15,148 shares of the business.
Weisman Howard J. sold 372 shares of PXMD for $175 on Jan 29 ’24. The Chief Executive Officer now owns 37,675 shares after completing the transaction at $0.47 per share. On Jan 29 ’24, another insider, LaRochelle Karen, who serves as the Director of the company, sold 78 shares for $0.48 each. As a result, the insider received 37 and left with 2,829 shares of the company.
Stock Price History:
Over the past 52 weeks, PXMD has reached a high of $38.93, while it has fallen to a 52-week low of $0.37.
Shares Statistics:
A total of 7.40M shares are outstanding, with a floating share count of 6.73M. Insiders hold about 9.12% of the company’s shares, while institutions hold 1.50% stake in the company.
Earnings Estimates
Its stock is currently analyzed by 1 different market analysts. On average, analysts expect EPS of -$0.43 for the current quarter, with a high estimate of -$0.43 and a low estimate of -$0.43, while EPS last year was –$. The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.3 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$1.09 and -$1.09 for the fiscal current year, implying an average EPS of -$1.09. EPS for the following year is $0, with — analysts recommending between $0 and $0.
